Connection

Miriam Lichtner to Biomarkers

Back to Details
This is a "connection" page, showing publications Miriam Lichtner has written about Biomarkers.
Miriam Lichtner
Connection Strength
0.235
Biomarkers
  1. Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon. PLoS One. 2017; 12(6):e0179400.
    View in: PubMed
    Score: 0.131
  2. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia. Front Immunol. 2021; 12:627548.
    View in: PubMed
    Score: 0.042
  3. Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection. PLoS One. 2018; 13(5):e0198174.
    View in: PubMed
    Score: 0.035
  4. Nox2 activation in Covid-19. Redox Biol. 2020 09; 36:101655.
    View in: PubMed
    Score: 0.010
  5. Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients. HIV Clin Trials. 2018 08; 19(4):158-162.
    View in: PubMed
    Score: 0.009
  6. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-?)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection. Clin Res Hepatol Gastroenterol. 2017 Dec; 41(6):644-655.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.